Prof Robert Wynn, Consultant Paediatric Haematologist and Director of Bone Marrow Transplant at Royal Manchester Children’s Hospital, leads the GRANS clinical trial. He tells us how this innovative treatment is showing promising results for children with hard-to-treat leukaemia.
Molecular radiotherapy (MRT) is an evolving form of children’s cancer treatment. Dr Mark Gaze, Caroline Elmagrahi and Georgia Azzopardi, of University College London Hospitals NHS Foundation Trust, tell us more about what it is and what work is being done to develop its usage.
Charley Scott’s daughter was diagnosed with cancer as a two-year-old. She tells us about an accessible new information resource that she and her husband Jon have created to help other children and families, influenced by their own experiences.
Artificial intelligence (AI) has helped scientists propose a promising new drug combination for DIPG brain tumours. Prof Chris Jones, Director of the Brain Tumour Research Centre of Excellence at the Institute of Cancer Research (ICR), and Dr Fernando Carceller, Paediatric Neuro-Oncology Consultant at The Royal Marsden Hospital, tell us more.
Professor Bob Phillips, Consultant Paediatric Oncologist and Contact’s medical adviser
Exploring alterations in amino acid metabolism as novel therapeutic targets in paediatric glial tumours using advanced metabolomics methods
Sarah Cripps’ son, Teddy, was diagnosed with acute myeloid leukaemia (AML) when 18 months old in April 2022. She explains the crucial role diet and nutrition played during Teddy’s treatment
Hannah Longstaff's daughter, Matilda, was diagnosed with acute lymphoblastic leukaemia (ALL) in February 2022, aged three. She tells us how Matilda’s appetite increased after being put on steroids and about the support she has received.
Emily Piszton was diagnosed with a type of brain tumour called craniopharyngioma in 2022, aged 11. Now 12, Emily explains how her tumour and its treatment caused her to gain weight, and what she did in response to this.
